Search research articles
Contact Us
Filters
Showing results (101-110 of 133) with videos related to
Page
of 14
Sort By:
Nature Medicine
|
April 15, 2020
Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae
Christoph M Ernst, Julian R Braxton, Carlos A Rodriguez-Osorio, et al.
Nature Medicine
|
June 27, 2020
Author Correction: Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae
Christoph M Ernst, Julian R Braxton, Carlos A Rodriguez-Osorio, et al.
Transfusion
|
June 14, 2021
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance
Clara Di Germanio, Graham Simmons, Kathleen Kelly, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2024
"Multiplexed screen identifies a <i>Pseudomonas aeruginosa</i> -specific small molecule targeting the outer membrane protein OprH and its interaction with LPS"
Bradley E Poulsen, Thulasi Warrier, Sulyman Barkho, et al.
Nature Chemical Biology
|
July 4, 2017
A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase
Samantha Wellington, Partha P Nag, Karolina Michalska, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 15, 2018
Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors
Chao Fang, Katie K Lee, Raymond Nietupski, et al.
Cell Chemical Biology
|
December 28, 2024
Discovery of a Pseudomonas aeruginosa-specific small molecule targeting outer membrane protein OprH-LPS interaction by a multiplexed screen
Bradley E Poulsen, Thulasi Warrier, Sulyman Barkho, et al.
Plos One
|
June 3, 2022
Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study
Sarah Naz-McLean, Andy Kim, Andrew Zimmer, et al.
Plos Pathogens
|
May 16, 2017
Systematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulence
Amy K Barczak, Roi Avraham, Shantanu Singh, et al.
Scientific Reports
|
December 9, 2022
Evaluation of the Access Bio CareStart rapid SARS-CoV-2 antigen test in asymptomatic individuals tested at a community mass-testing program in Western Massachusetts
Sara Suliman, Wilfredo R Matias, Isabel R Fulcher, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 133) with videos related to
Sort By:
Page
of 14
Nature Medicine
|
April 15, 2020
Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae
Christoph M Ernst, Julian R Braxton, Carlos A Rodriguez-Osorio, et al.
Nature Medicine
|
June 27, 2020
Author Correction: Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae
Christoph M Ernst, Julian R Braxton, Carlos A Rodriguez-Osorio, et al.
Transfusion
|
June 14, 2021
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance
Clara Di Germanio, Graham Simmons, Kathleen Kelly, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2024
"Multiplexed screen identifies a <i>Pseudomonas aeruginosa</i> -specific small molecule targeting the outer membrane protein OprH and its interaction with LPS"
Bradley E Poulsen, Thulasi Warrier, Sulyman Barkho, et al.
Nature Chemical Biology
|
July 4, 2017
A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase
Samantha Wellington, Partha P Nag, Karolina Michalska, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 15, 2018
Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors
Chao Fang, Katie K Lee, Raymond Nietupski, et al.
Cell Chemical Biology
|
December 28, 2024
Discovery of a Pseudomonas aeruginosa-specific small molecule targeting outer membrane protein OprH-LPS interaction by a multiplexed screen
Bradley E Poulsen, Thulasi Warrier, Sulyman Barkho, et al.
Plos One
|
June 3, 2022
Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study
Sarah Naz-McLean, Andy Kim, Andrew Zimmer, et al.
Plos Pathogens
|
May 16, 2017
Systematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulence
Amy K Barczak, Roi Avraham, Shantanu Singh, et al.
Scientific Reports
|
December 9, 2022
Evaluation of the Access Bio CareStart rapid SARS-CoV-2 antigen test in asymptomatic individuals tested at a community mass-testing program in Western Massachusetts
Sara Suliman, Wilfredo R Matias, Isabel R Fulcher, et al.
Page
of 14